Rani Therapeutics Holdings Inc (RANI) Stock Analysis

Rani Therapeutics Holdings Inc (RANI) is a publicly traded company in the HEALTHCARE sector. It trades at $0.86, carries a market capitalization of $130.72M. This page summarizes the public market data, fundamentals, and frequently asked questions for RANI, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.86
• Market Cap: $130.72M
• EPS: $-0.27
• 52-Week High: $3.87
• 52-Week Low: $0.39

Market Sentiment

Rani Therapeutics Holdings Inc currently has a Neutral sentiment score of 0.02.

About Rani Therapeutics Holdings Inc

None

GNG Research Analysis

GNG Research scores Rani Therapeutics Holdings Inc (RANI) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RANI.

Frequently Asked Questions

Does RANI pay dividends?

Rani Therapeutics Holdings Inc (RANI) does not currently pay a regular dividend.

What is RANI's market cap?

Rani Therapeutics Holdings Inc (RANI) has a market capitalization of $130.72M with a current stock price of $0.86.